GSK3B and type 2 diabetes mellitus: In the T2DM diabetic mouse group, the phosphorylated PTEN was upregulated, while the phosphorylation levels of c-Raf, AKT, and GSK-3β were significantly decreased compared with the control group, revealing that the AKT pathway activity in the diabetic mouse liver was attenuated.